Modulari-T Bioscience Analysis: $0.5M Raised
What is Modulari-T Bioscience?
Modulari-T Bioscience specializes in AI-driven protein design for innovative therapies. Their unique approach focuses on synthetic immune receptors tailored for various cell types. This technology aims to unlock safe and effective treatments for oncology, autoimmunity, and fibrosis.
HQ Country
Montreal, Canada
Employees
1-10
Founded
2021
Industry
Biotech, HealthTech, AI/ML
Product Features & Capabilities
- Modular Actuation Receptor Cells for enhanced immune response
- Modular Vector (MoVE) platform for targeted delivery
- AI protein design engine for optimized therapeutic solutions
- Immune cell-specific vectors for precise activation
- Scalable cell therapy solutions for diverse applications.
How much Modulari-T Bioscience raised
1: - $500,000
April 3, 2023Lead Investor: Y Combinator, Pioneer Fund, Metaplanet
